Literature DB >> 21110766

Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.

Aadilah Omar1, Katarina Jovanovic, Bianca Da Costa Dias, Danielle Gonsalves, Kiashanee Moodley, Robert Caveney, Vusi Mbazima, Stefan F T Weiss.   

Abstract

IMPORTANCE OF THE FIELD: The 37/67 kDa laminin receptor precursor/laminin receptor (LRP/LR) represents a multifunctional protein located on the cell surface, in the cytosol and the nucleus. The receptor acts as a mediator for cell adhesion, cell proliferation and cell differentiation. It is a key player in invasion and adhesion, major functions of several important metastatic cancer types. The receptor hampers apoptosis thereby favoring cancer progression. LRP/LR plays a major role as a cell surface receptor in prion disorders and may be of considerable importance for other neurodegenerative diseases such as Alzheimer's disease. A series of viruses including Sindbis virus, Dengue virus and Adeno-associated virus use LRP/LR as attachment receptors. Bacteria and Candida albicans use the receptor for pathogenesis. AREAS COVERED IN THIS REVIEW: Background and patented biological approaches for therapeutic modulation of LRP/LR in neurodegenerative diseases, cancer, viral disorders, bacterial and yeast infections. WHAT THE READER WILL GAIN: A comprehensive review of the role of LRP/LR in infectious and non-infectious diseases and an insightful assessment of published or patented biological approaches for the therapeutic modulation of LRP/LR. TAKE HOME MESSAGE: Molecular tools such as antibodies directed against LRP/LR have the potential to act as promising alternative therapeutics for the treatment of various diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110766     DOI: 10.1517/13543776.2011.539203

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  20 in total

Review 1.  Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.

Authors:  Vincent DiGiacomo; Daniel Meruelo
Journal:  Biol Rev Camb Philos Soc       Date:  2015-01-28

Review 2.  Structural and mechanistic commonalities of amyloid-β and the prion protein.

Authors:  Bianca Da Costa Dias; Katarina Jovanovic; Danielle Gonsalves; Stefan F T Weiss
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

3.  Global Alzheimer Research Summit: basic and clinical research: present and future Alzheimer research.

Authors:  Danielle Gonsalves; Katarina Jovanovic; Bianca Da Costa Dias; Stefan F T Weiss
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

4.  Alimentary prion infections: Touchdown in the intestine.

Authors:  Bianca Da Costa Dias; Katarina Jovanovic; Stefan F T Weiss
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

Review 5.  Targeting prion protein interactions in cancer.

Authors:  Tiago G Santos; Marilene H Lopes; Vilma R Martins
Journal:  Prion       Date:  2015       Impact factor: 3.931

6.  Anti-LRP/LR specific antibody IgG1-iS18 significantly impedes adhesion and invasion in early and late stage colorectal carcinoma cells.

Authors:  Leila Vania; Carryn J Chetty; Eloise Ferreira; Stefan F T Weiss
Journal:  Mol Med       Date:  2016-09-08       Impact factor: 6.354

7.  The potential roles of a laminin receptor in adhesion and apoptosis of cells of the marine bivalve Meretrix meretrix.

Authors:  Yanan You; Pin Huan; Xiaomei Wang; Baozhong Liu
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

8.  In vitro inhibition of angiogenesis by antibodies directed against the 37kDa/67kDa laminin receptor.

Authors:  Raksha Khusal; Bianca Da Costa Dias; Kiashanee Moodley; Clement Penny; Uwe Reusch; Stefan Knackmuss; Melvyn Little; Stefan F T Weiss
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

9.  Downregulation of the non-integrin laminin receptor reduces cellular viability by inducing apoptosis in lung and cervical cancer cells.

Authors:  Kiashanee Moodley; Stefan F T Weiss
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.

Authors:  Katarina Jovanovic; Danielle Gonsalves; Bianca Da Costa Dias; Kiashanee Moodley; Uwe Reusch; Stefan Knackmuss; Clement Penny; Marc S Weinberg; Melvyn Little; Stefan F T Weiss
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.